These data are consistent with the findings of the XFe96 analyzer (Supplementary Figure 3 and Figure 3a), showing that in response to enhanced WNT3A signaling, PTENWT melanoma cells exhibit significantly reduced cellular metabolism, including both oxidative phosphorylation and glycolytic capacity. This evidence concerns the gene WNT3A and melanoma.